Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX8LOI
|
||||
| Drug Name |
Z-leu-Val-Agly-Val-OBzl
|
||||
| Synonyms |
CHEMBL3143135
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C32H45N5O7
|
||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NNC(=O)N[C@@H](C(C)C)C(=O)OCc2ccccc2
|
||||
| InChI |
InChI=1S/C32H45N5O7/c1-20(2)17-25(33-32(42)44-19-24-15-11-8-12-16-24)28(38)34-26(21(3)4)29(39)36-37-31(41)35-27(22(5)6)30(40)43-18-23-13-9-7-10-14-23/h7-16,20-22,25-27H,17-19H2,1-6H3,(H,33,42)(H,34,38)(H,36,39)(H2,35,37,41)/t25-,26-,27-/m0/s1
|
||||
| InChIKey |
QYEUFPXQJIQXLI-QKDODKLFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | RANKL/RANK Signaling Pathway | ||||
| Osteoclast Signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.